Results 191 to 200 of about 1,850,678 (233)
Some of the next articles are maybe not open access.
Systemic sclerosis or scleroderma
Independent Nurse, 2007This article provides a definition of systemic sclerosis orscleroderma and its epidemiology
Josip Car, Aziz Sheikh
openaire +2 more sources
Current Rheumatology Reports, 2001
Systemic scleroderma in children is very rare and is considered similar to adult-onset disease. In adults, new etiopathogenetic and therapeutic approaches have emerged in recent years. For instance, it has been shown that microchimerism could play a role in disease pathogenesis and that immunoablation followed by stem cell rescue could be of potential ...
openaire +3 more sources
Systemic scleroderma in children is very rare and is considered similar to adult-onset disease. In adults, new etiopathogenetic and therapeutic approaches have emerged in recent years. For instance, it has been shown that microchimerism could play a role in disease pathogenesis and that immunoablation followed by stem cell rescue could be of potential ...
openaire +3 more sources
Systemic scleroderma: a spatiotemporal clustering
Internal Medicine Journal, 2005AbstractBackground and aims: The aetiology of systemic scleroderma remains poorly understood. Twin studies suggest a low genetic input. Of the incriminated environmental agents, silica and vinyl chloride monomer exposure appear the most convincing. Spatiotemporal clustering has been demonstrated only three times previously.
Englert, H+7 more
openaire +3 more sources
Arthritis & Rheumatism, 1981
A kindred is reported which contains 3 siblings with scleroderma, 2 siblings with Raynaud's phenomenon, and 2 first-degree relatives with histories suggestive of connective tissue syndromes. Studies of microvascular morphology and flow, serum endothelial
W. B. Sheldon+7 more
semanticscholar +1 more source
A kindred is reported which contains 3 siblings with scleroderma, 2 siblings with Raynaud's phenomenon, and 2 first-degree relatives with histories suggestive of connective tissue syndromes. Studies of microvascular morphology and flow, serum endothelial
W. B. Sheldon+7 more
semanticscholar +1 more source
Journal of the American Academy of Dermatology, 1988
Systemic scleroderma is a generalized disease of connective tissue involving mainly the skin, the gastrointestinal tract, the lungs, the heart, and the kidneys. It can be present in different forms, of which acroscleroderma, with limited cutaneous and extracutaneous involvement, and diffuse scleroderma within a more rapid progression are most ...
Michael Meurer, Thomas Krieg
openaire +3 more sources
Systemic scleroderma is a generalized disease of connective tissue involving mainly the skin, the gastrointestinal tract, the lungs, the heart, and the kidneys. It can be present in different forms, of which acroscleroderma, with limited cutaneous and extracutaneous involvement, and diffuse scleroderma within a more rapid progression are most ...
Michael Meurer, Thomas Krieg
openaire +3 more sources
Radiology, 1976
The radiological, clinical, and laboratory features found in seven patients with scleroderma-SLE overlap, including three with mixed connective tissue disease (MCTD), are described. There were no distinctive roentgenographic features which differentiated
Terry M. Sliver+3 more
semanticscholar +1 more source
The radiological, clinical, and laboratory features found in seven patients with scleroderma-SLE overlap, including three with mixed connective tissue disease (MCTD), are described. There were no distinctive roentgenographic features which differentiated
Terry M. Sliver+3 more
semanticscholar +1 more source
Progressive Systemic Sclerosis (Scleroderma)
New England Journal of Medicine, 1953THE skin manifestations of scleroderma have long been recognized and adequately described. These features are usually identified readily, particularly in the later phases of the disease when the spectacular, hardened, bound-down, wrinkleless appearance of the skin is so characteristic as to supply a descriptive name for the illness. This term refers to
Theodore B. Bayles+2 more
openaire +4 more sources
Scleroderma-Inducing Glycosaminoglycan in the Urine of Patients with Systemic Scleroderma
Dermatology, 1978A glycosaminoglycan with scleroderma-inducing effect was isolated and partially purified from the urine of patients with systemic scleroderma. The glycosaminoglycan was an N-sulfated glycosaminoglycuronan and its high total sulfate and 2,5-anhydromannose contents suggest that the glycosaminoglycan is a degradation product of heparin or polysulfated ...
Hidekazu Ishikawa+3 more
openaire +3 more sources
Mortality in Systemic Sclerosis (Scleroderma)
QJM: An International Journal of Medicine, 1992Two hundred and thirty-seven patients with systemic sclerosis were followed prospectively in a scleroderma clinic. The overall 3, 6, and 9-year survival rates were 86, 76 and 61 per cent respectively. Renal, cardiac and pulmonary disease, and older age at enrollment were adverse prognostic factors associated with reduced survival.
M Aubrey+9 more
openaire +3 more sources
HLA and autoimmunity in scleroderma (systemic sclerosis).
International Reviews of Immunology, 1995Scleroderma or systemic sclerosis (SSc) has been associated with certain class II antigens of the major histocompatibility complex (MHC), including HLA-DR1, DR2, DR3, DR5, and DR52.
F. Arnett
semanticscholar +1 more source